Recurrent mitral regurgitation after repair: Should the mitral valve be re-repaired?  by Suri, Rakesh M. et al.
S
A
C
D
R
m
R
R
1
A
CDurgery for
cquired
ardiovascular
iseaseecurrent mitral regurgitation after repair: Should the
itral valve be re-repaired?
akesh M. Suri, MD, DPhil, Hartzell V. Schaff, MD, Joseph A. Dearani, MD, Thoralf M. Sundt, III, MD,
ichard C. Daly, MD, Charles J. Mullany, MB, MS, Maurice Enriquez-Sarano, MD, and Thomas A. Orszulak, MD
O
r
M
p
r
y
R
d
1
(
p
i
r
a
s
.
o
a
m
(
i
r
C
n
a
i
M
i
pFrom the Division of Cardiovascular Sur-
gery, Mayo Clinic College of Medicine,
Rochester, Minn.
Maurice Enriquez-Sarano reports consul-
tant fees, lecture fees, and grant support
from Edwards Lifesciences.
Read at the Eighty-sixth Annual Meeting of
The American Association for Thoracic
Surgery, Philadelphia, Pa, April 29-May 3,
2006.
Received for publication April 30, 2006;
revisions received June 30, 2006; accepted
for publication July 12, 2006.
Address for reprints: Rakesh M. Suri, MD,
DPhil, Division of Cardiovascular Surgery,
Mayo Clinic College of Medicine, 200 First
St SW, Rochester, MN 55905 (E-mail: suri.
rakesh@mayo.edu).
J Thorac Cardiovasc Surg 2006;132:1390-7
0022-5223/$32.00
Copyright © 2006 by The American Asso-
ciation for Thoracic Surgery1
doi:10.1016/j.jtcvs.2006.07.018
390 The Journal of Thoracic and Cardbjective: We sought to evaluate the clinical and echocardiographic outcomes of
eoperation for failed mitral valve repair.
ethods: One hundred forty-five patients with recurrent mitral regurgitation after
rimary mitral valve repair of degenerative leaflet prolapse underwent mitral valve
eoperations between January 1, 1970, and January 1, 2005. The mean age was 66
ears, and 102 (70%) were men.
esults: The mean duration from initial repair to reoperation was 4.1 years (standard
eviation   5.1 years). Indications for reoperation were regurgitation alone (n 
09 [75%]), hemolysis (n  27 [19%]), obstruction from systolic anterior motion
n  3 [2%]), endocarditis (n  3 [2%]) and stenosis-other (n  3 [2%]). New
athology was found in 80 (55%) patients, and failure of the initial repair was found
n 61 (42%) patients. The mitral valve was re-repaired in 64 (44%) patients and
eplaced in 81 (56%) patients. Early operative mortality was similar after re-repair
nd replacement (1.6% vs 4.9%, P  .38). Independent predictors of improved
urvival on multivariate analysis were mitral re-repair (hazard ratio  0.44, P 
03), younger age (hazard ratio  1.06, P  .001), and an operative indication
f mitral regurgitation alone (hazard ratio  0.31, P  .005). Seven patients had
third mitral operation (all replacements), 6 after re-repair and 1 after replace-
ent. At last follow-up echocardiogram (n  96), ejection fraction was greater
P  .001) and left ventricular end-systolic dimension was smaller (P  .009)
n patients undergoing re-repair compared with values in those undergoing valve
eplacement.
onclusion: Recurrent mitral regurgitation after prior repair is frequently caused by
ew valve pathology. Mitral re-repair is performed in almost half of patients and is
ssociated with superior survival, improved ejection fraction, and greater regression
n ventricular dimension compared with valve replacement.
itral valve (MV) repair is the standard of care for the correction of
significant mitral regurgitation (MR) caused by degenerative valve dis-
ease.1-5 Valve repair is associated with superior survival and equivalent,
f not better, durability compared with valve replacement. MV reoperation after
rimary repair has been reported to occur with a linearized hazard rate of 0.5% to
.5% per year.6 There has been hesitance to perform a second mitral repair because
iovascular Surgery ● December 2006
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A
CDf concern that patients with a failed initial repair might
ave poor tissue quality, limiting the durability of re-repair.
lso, there has been speculation that secondary MV repair
ight have greater risk than valve replacement.
Little is known regarding the effects of re-repair versus
eplacement on survival, durability, and normalization of
eft ventricular (LV) size and function. The objective of this
tudy was to examine patients presenting with recurrent
egurgitation after primary MV repair of leaflet prolapse, to
nalyze causes of technical failure after the first repair, and
o determine factors predicting survival and durability after
eoperation.
atients and Methods
his was a retrospective review of patients undergoing surgical
orrection (repair or replacement) of recurrent MV regurgitation
fter primary MV repair for regurgitation caused by degenerative
eaflet prolapse. The study was reviewed and approved by the
ayo Clinic College of Medicine Institutional Review Board. The
eed for individual patient consent was waived because relevant
dentifiers were not included in the database. Included were those
aving concomitant coronary bypass (coronary artery bypass graft-
ng) or closure of a secundum atrial septal defect/patent foramen
vale. We excluded patients who declined involvement in clinical
esearch, those who underwent conversion to replacement at the
ime of the initial operation, and those who had an initial diagnosis
f MR caused by congenital or ischemic heart disease or other
orms of cardiomyopathy. Also excluded were patients with sig-
ificant MV stenosis or those with endocarditis causing leaflet
efects/subvalvular abscess at the time of primary MV repair.
Between January 1, 1970, and January 1, 2005, a total of 145
atients underwent mitral reoperations for recurrent MR at Mayo
linic Rochester. One hundred seven patients had their first MV
epair at Mayo Clinic Rochester (5% of 2122 patients undergoing
rimary MV repair for degenerative leaflet prolapse during the
tudy interval), and 38 had their first operation elsewhere. A total
f 64 (44%) patients underwent MV re-repair, and 81 (56%)
nderwent replacement of the previously repaired valve. The mean
nterval between the initial operation and reoperation was 4.1 
.1 years. The date of reoperation occurred within the first 3
onths after the primary repair in 26 (18%) patients. A total of 6
atients undergoing re-repair and 1 undergoing replacement had a
hird mitral operation (second mitral reoperation). All 7 of these
ad valve replacement. The indications for reoperation were re-
orded from preoperative clinical assessments and echocardio-
rams. Findings at the time of the operation were determined from
review of the operative notes. The mean duration of follow-up in
Abbreviations and Acronyms
AL  anterior leaflet
LV  left ventricular
MRmitral regurgitation
MVmitral valve
PL  posterior leafleturvivors was 3.3 ( 4.1) years.
*
N
The Journal of Thoracicurgical Procedure
oth the indications for primary MV repair and the surgical
echniques used evolved over the 35-year period. During the third
ecade of the study (1990s), we adopted a strategy of earlier
rimary MV repair for regurgitation caused by leaflet prolapse on
he basis of quantitative echocardiographic criteria.2 The most
requent lesion for which patients underwent initial surgical cor-
ection of MR at Mayo Clinic was isolated posterior leaflet (PL)
rolapse of the middle scallop caused by either chordal elongation
r chordal rupture. The most common method of correction during
he initial operation was triangular resection and suture repair of
he involved portion of the PL supplemented by a standard-length
63-mm) flexible posterior annuloplasty band.7,8 During the first 2
ecades of the study, anterior leaflet (AL) prolapse was corrected
y means of chordal shortening, chordal transfer, or commissural
nnuloplasty. More recently (after 1990), we used artificial poly-
etrafluoroethylene* neochordae8 for repair of AL prolapse and, in
elected patients, leaflet plication. Indications for reoperation were
ecurrent MR with or without associated complications. Tech-
iques used for MV re-repair were generally similar to those used
n primary MV repair.
tatistical Analysis
roup statistics were expressed as means  1 standard deviation.
ategoric variables were compared between groups by using the
2 test for independence or the Fisher exact test. Two-sample
tests were used to compare continuous variables between groups.
urvival and reoperation end points were estimated by using the
aplan-Meier method (actuarial). Multivariate models to identify
otential risk factors for these end points were investigated by
sing Cox proportional hazards and were constructed with step-
ise selection techniques. P values of .05 or less were considered
ignificant.
esults
aseline Characteristics
aseline characteristics of patients are presented in Table 1.
atients undergoing MV replacement were slightly more
ymptomatic and had greater left atrial dimensions before
eoperation than patients undergoing valve re-repair. All
ther aspects of the preoperative risk profiles were similar
omparing those who underwent MV re-repair versus those
ho underwent prosthetic replacement.
ndications for Reoperation
he indications for a second MV procedure are shown in
able 2. A total of 109 (75%) patients underwent reopera-
ions for significant regurgitation alone. The remaining fac-
ors responsible for a decision to reoperate were hemolysis
n 27 (19%), dynamic outflow tract obstruction caused by
ystolic anterior motion of the anterior mitral leaflet in 3
2%), endocarditis in 3 (2%), MV stenosis in 1 (1%), and
other” in 2 (1%). Patients were more likely to have valve
eplacement at reoperation if the preoperative indicationGore-Tex neochordae, registered trademark of W. L. Gore & Associates, Inc.,
ewark, Del.
and Cardiovascular Surgery ● Volume 132, Number 6 1391
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A
CDas MR alone and were more likely to have re-repair if
emolysis was the cause. Of the 27 patients with hemolysis,
he mean MR grade at reoperation was 3.4, and the mean
nterval from first operation to reoperation was 1.1 years.
eoperation
he findings at reoperation are shown in Table 3. Overall,
he surgically determined factor or factors contributing to
ecurrent MR included the AL in 65 (45%), the PL in 61
42%), ring annuloplasty dehiscence in 42 (29%), and
hordal rupture in 20 (14%). New valve pathology was
etermined to be the responsible cause of recurrent MR in
0 (55%) patients, and technical failure of the primary
ABLE 1. Baseline characteristics
Re-repair Replacement P value
64 (44%) 81 (56%)
ge (y) 64  13 67 11 .24
ex .15
Male 49 (77%) 53 (65%)
Female 15 (23%) 28 (35%)
trial fibrillation 7 (11%) 10 (12%) .79
YHA class .01
I 7 (11%) 0 (0%)
II 29 (45%) 40 (49%)
III 25 (39%) 32 (40%)
IV 3 (5%) 9 (11%)
reoperative MR (n  132) .20
Trivial 2 (3%) 1 (1%)
Mild 3 (5%) 2 (3%)
Moderate 14 (23%) 8 (11%)
Severe 42 (68%) 60 (85%)
reoperative EF (%) (n  136) 57 12 56 11 .23
reoperative LVEDD (mm)
(n  109)
56  7 57 8 .47
reoperative LVESD (mm)
(n  103)
37  8 38 8 .57
reoperative LA size (mm)
(n  83)
56  13 60 12 .04
ecade 1990 vs 1990 57 (89%) 68 (84%) .38
YHA, New York Heart Association; MR, mitral regurgitation; EF, ejection
raction; LVEDD, left ventricular end-diastolic dimension; LVESD, left ven-
ricular end-systolic dimension; LA, left atrial.
ABLE 2. Indications for reoperation
ariable Overall Re-repair Replacement P value
egurgitation alone 109 (75%) 40 (63%) 69 (85%) .002
emolysis 27 (19%) 20 (31%) 7 (9%) .001
AM obstruction 3 (2%) 2 (3%) 1 (1%) .43
ndocarditis 3 (2%) 0 3 (4%) .12
ther 2 (1%) 1 (2%) 1 (1%) .87
tenosis 1 (1%) 1 (2%) 0 .26rAM, Systolic anterior motion of the anterior mitral leaflet.
392 The Journal of Thoracic and Cardiovascular Surgery ● Decepair was most responsible in 61 (42%) patients. The cause
f MR at reoperation was unclear in 4 (3%) patients. Pa-
ients having MV re-repair were more likely to have a
pecific anatomic cause for recurrent MR identified by the
urgeon at reoperation, such as annuloplasty dehiscence or
echnical failure of the prior repair. Discovering new pa-
hology was associated with a tendency to replace the MV.
At reoperation, 64 patients underwent MV re-repair, and
1 underwent valve replacement. During re-repair, a mod-
fication of the annuloplasty was carried out in 52 of 64, an
L procedure was performed in 33 of 64, and the PL was
ddressed in 32 of 64. Concomitant procedures were per-
ormed in 38 patients and included coronary artery bypass
rafting in 14 (10%), tricuspid valve repair in 12 (8%),
ortic valve replacement in 8 (6%), the Cox maze procedure
n 4 (2.8%), atrial septal defect closure in 1 (0.7%), and
atent foramen ovale closure in 1 (0.7%). The operative
ortality after valve replacement was 4.9% (4 patients), and
hat after mitral re-repair was 1.6% (1 patient). Where data
ere available on predismissal echocardiography, 97% (59/
1) of patients undergoing re-repair and 98% (64/65) of
hose undergoing valve replacement had no greater than
ild MR.
nivariate and Multivariate Predictors of
ate Mortality
nivariate analysis and multivariate models were constructed
o determine the influence of preoperative and intraopera-
ive variables on late mortality (30 days) after reoperation.
he univariate survival advantage associated with re-repair
s shown in Figure 1. On multivariate analysis, 3 indepen-
ent factors were associated with improved survival: MV
e-repair, younger age, and the preoperative indication of
ure MR (Table 4).
nivariate Predictors of Third Mitral Operation
total of 7 patients (6 undergoing re-repair and 1 under-
oing replacement) underwent a third MV operation at a
ean of 5.7 years after the second operation (operative
ortality, 0%). The actuarial survival free of subsequent
ABLE 3. Findings at reoperation
bnormal findings Overall Re-repair Replacement P value
nterior leaflet 65 (45%) 27 (42%) 38 (47%) .57
osterior leaflet 61 (42%) 27 (42%) 34 (42%) .98
nnuloplasty 42 (29%) 30 (47%) 12 (15%) .001
hordal rupture 20 (14%) 7 (11%) 13 (16%) .38
ode of failure
New pathology 80 (55%) 27 (42%) 53 (65%) .005
Technical 61 (42%) 36 (56%) 25 (31%) .002
Unclear 4 (3%) 1 (2%) 3 (4%) .43eoperation after the first MV reoperation was 93% at 5
ember 2006
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A
CDears overall. The 5-year actuarial freedom from reopera-
ion after re-repair was 83%, and the linearized risk of
eoperation was 3.4% per year. The only univariate predic-
or of a third MV operation was performance of an AL
rocedure at the time of re-repair. The number of events was
nsufficient to perform multivariate modeling.
ollow-up Data
t the date of last contact, 43 (100%) of 43 patients under-
oing re-repair were in New York Heart Association class
/II versus 31 (91%) of 34 after replacement. The final
vailable follow-up echocardiograms (between 1-5 years,
 96) were analyzed to assess LV size and function after
V re-repair versus replacement. These were performed a
ean of 946 days after re-repair and 915 days after valve
eplacement (Table 5). Patients undergoing MV re-repair at
he second operation had significantly better ejection fraction
nd smaller LV end-systolic dimension during follow-up
ompared with those undergoing MV replacement.
iscussion
his is the first study to compare the outcomes of MV
e-repair versus replacement for recurrent MR after primary
epair of degenerative MV prolapse. Our results indicate
hat reoperation was most often required for recurrent re-
urgitation and that the cause was similarly distributed
etween failure of the previous repair and new valve pa-
igure 1. Kaplan-Meier probability of late survival (>30 days or
fter discharge from the hospital) after mitral valve re-repair or
eplacement at reoperation for recurrent mitral regurgitation. The
ate survival associated with mitral valve re-repair is greater than
hat seen after mitral replacement (mortality hazard ratio for
e-repair, 0.49; P  .05 vs valve replacement).hology. MV re-repair was performed in just under half of t
The Journal of Thoracicll patients in our series. Importantly, we found that re-
epair is clearly beneficial, conveying improved survival,
long with better recovery of LV function and greater LV
egression, compared with valve replacement. If MV re-
epair is technically possible, it should be the favored choice
t reoperation.
The indications for reoperation and intraoperative find-
ngs both influenced the choice of surgical procedure. Sig-
ificant MR alone was the most frequent indication for
eoperation after initial MV repair, as has been shown in
rior reports,9 and was associated with a tendency to per-
orm valve replacement over re-repair (85% vs 63%, P 
002). Technical reasons for failure of the primary MV
epair were discovered to be important in 42% of patients,
hich more frequently led to be re-repair (56%) over re-
lacement (31%, P  .002). Discovering a specific ana-
omic cause for disruption of the prior repair and, specifi-
ally, annuloplasty dehiscence was more prevalent in those
ndergoing re-repair (47% vs 15%, P  .001). This obser-
ation underlines the fact that the ability to discern an
natomic reason for failure of the first repair is important if
second repair is to be considered. It also reaffirms the
mportance of reliable intraoperative and predischarge echo-
ardiography to identify those with early repair failure so
hat surgical reintervention can be undertaken before leav-
ng the hospital, as others have suggested.9 Finding new
alve pathology at reoperation might have influenced the
ecision to replace the MV (42% vs 65%, P  .005). This
endency might have been associated with a concern that
isease progression in remaining leaflet tissue would in-
rease the likelihood of a third MV operation.
The observation that roughly half of all patients (55%)
ave new MV pathology causing recurrent MR after
rimary repair differs from the reports of others, who
ave suggested that technical failure was the most com-
on finding at reoperation.9,10 It is possible that the
revalence of rheumatic and ischemic MV disease in
hese studies might have influenced both the cause of
epair failure and the stated preference for valve replace-
ent at reoperation.
The incidence of hemolysis after MV repair is unknown,
nd the optimal clinical management is still a topic of
ebate. In this series hemolysis as a cause for reoperation
fter initial MV repair of degenerative leaflet prolapse was
nusual (19%) but was also a factor favoring re-repair. A
ecent report suggested that 90% of patients presenting with
emolysis after prior MV repair required MV reoperations
or surgical correction.11 The operative techniques used to
liminate the regurgitant jet and to prevent the recurrence of
emolysis while preserving the native MV have been de-
cribed elsewhere.11-14 Several groups have published their
xperience with reoperation for this condition,11-13,15,16 and
here has been a suggestion that MV replacement might be
and Cardiovascular Surgery ● Volume 132, Number 6 1393
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1
A
CDhe treatment of choice.11 Our current data indicate that
e-repair for hemolysis is effective and is not a risk factor
or a third mitral operation.
Operative mortality in our study was 1.6% after re-repair
nd 4.9% after replacement. El Asmar and colleagues10
ound an overall reoperative mortality of 1.4% in a series in
hich 85% of repair failures were followed by replacement.
illinov and associates9 studied a mixed population of pa-
ients (degenerative, 59%; rheumatic, 20%; ischemic, 16%;
ABLE 4. Univariate and multivariate predictors of late mo
ariable Univariate HR U
ge 1.06
ale sex 0.58
trial fibrillation 1.43
YHA class 1.55
iabetes 4.36
HF 2.27
ecade 1990 vs 1990 0.85
ndications
MR alone 0.62
Hemolysis 1.28
indings
MR alone 3.30
Anterior leaflet 0.65
Posterior leaflet 0.81
Annuloplasty 1.11
Ruptured chordae 0.63
ode of failure
Technical 0.75
New pathology 1.15
eoperation thromboembolism 2.94
eoperation hemolysis 1.36
ollow-up MR grade 0.82
reoperative EF (%) 1.01
reoperative LVEDD (mm) 1.01
reoperative LVESD (mm) 1.03
reoperative LA size (mm) 1.01
ime to reoperation 1.00
e-repair vs replacement 0.49
ABG 2.22
YHA, New York Heart Association; CHF, congestive heart failure; MR, m
imension; LVESD, left ventricular end-systolic dimension; LA, left atrial; C
ABLE 5. Follow-up echocardiographic data
ariable Re-repair Replacement P value
ime to last
echocardiogram (d)
946 915 .65
F 55 (39) 44 (35) .001
VEDD 55 (43) 57 (32) .30
VESD 38 (36) 44 (29) .009
F, Ejection fraction; LVEDD, left ventricular end-diastolic dimension;
fiVESD, left ventricular end-systolic dimension.
394 The Journal of Thoracic and Cardiovascular Surgery ● Decndocarditis, 4%; and congenital, 1%), reporting an early
ortality after re-repair of 8.6%. A similar operative risk,
.9%, was reported by Niederhauser and coworkers.17 Our
tudy examines a cohort of patients who are relatively
omogeneous. In limiting our review to degenerative MV
isease, we have attempted to focus on the actual reopera-
ive risk associated with re-repair versus replacement in this
opulation.
MV re-repair was an independent predictor of improved
ate survival in our study, despite similar preoperative risk
rofiles to those undergoing MV replacement. Moreover, re-
epair led to superior recovery of ejection fraction and more
omplete regression of LV dimensions toward normal, as
as been shown after primary valve repair.6 It has also been
emonstrated elsewhere that greater LV function and smaller
V dimensions after primary MV surgery are associated
ith a survival advantage during long-term follow-up.18-20
his might explain the observed benefit in late survival that
e have seen in our current series after re-repair. The
ity
iate P value Multivariate HR Multivariate P value
.002 1.06 .001
.10
.34
.06
.05
.04
.65
.19 0.31 .005
.55
.10
.21
.54
.76
.38
.38
.65
.08
.41
.44
.62
.64
.17
.47
.91
.05 0.44 .03
.08
regurgitation; EF, ejection fraction; LVEDD, left ventricular end-diastolic
coronary artery bypass grafting.rtal
nivar
itralndings in this report challenge the assumption that MV
ember 2006
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A
CDeplacement is the conservative choice for correction of
ecurrent MR. The previously established benefits of pri-
ary MV repair on survival, LV size, and function persist
fter re-repair.
Although the durability of MV replacement was
lightly greater than that of re-repair at reoperation, the
ifference between the 2 groups could not be statistically
ifferentiated. Surgical correction of the AL during MV
e-repair was performed in 33 (52%) of 64 patients un-
ergoing re-repair and was the only univariate risk factor
o be associated with the need for a third mitral operation.
ecause the majority of the procedures in this report were
arried out between 1980 and 2000, many patients had
orrection of AL prolapse with methods that are now
nown to be less durable than chordal replacement.5,21
ur recent results concur with those of others who have
ound no significant difference in MV reoperation rates
fter primary repair of isolated PL prolapse versus that
nvolving the AL in the current era.6,22,23 The improved
urability of primary AL repair will also likely influence
he results of re-repair in the future.
imitations
his is a retrospective review and is associated with the
raditional limitations. It is possible that we selected a
roup of patients who were more likely to be followed for
ome distinguishing feature. Although we captured all
atients presenting for reoperation at our institution, re-
ardless of the location of the first repair, it is conceiv-
ble that this group differs from those who had reopera-
ions elsewhere. Finally, because of the length of the
eriod over which this study was completed, there are
ariations in the frequency and extent of echocardio-
raphic follow-up.
linical Implications
elaying surgical reintervention for recurrent severe MR
fter primary MV repair can be deleterious. Identification
f MV-related hemolysis, an anatomic abnormality of the
rior repair, or technical failure at reoperation all in-
rease the likelihood of performing a second MV repair.
ust under half of all patients in this study underwent
e-repair at reoperation. The proportion of those who
ave anatomy amenable to re-repair is likely higher than
his. Re-repair frequency might be limited either by sur-
eon bias or patient concern regarding a third operation.
hereas patients have previously been counseled to ac-
ept MV replacement as the more conservative choice
fter failure of primary MV repair, the survival advan-
age, durability, and improvements in LV size and func-
ion associated with re-repair should motivate clinicians
o offer this opportunity to patients.
1
The Journal of Thoraciconclusions
itral re-repair is currently performed in almost half of all
atients with recurrent MR after failed primary repair of
egenerative MV disease. The reoperation rate after re-
epair is 3.4% per year, and will likely improve as the
esults of more recent valvuloplasty techniques for AL
epair become available. MV re-repair should be offered as
he preferred approach to preserve longevity along with LV
ize and function at reoperation.
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iscussion
r A. Marc Gillinov (Cleveland, Ohio). In this excellent and very
lear review, you describe the treatment for recurrent MR after a
rimary operation for degenerative disease or prolapse, and in your
eries you re-repaired nearly half of the valves. This is an impor-
ant topic because although failure of a repair is uncommon, as the
umber of repairs increase, we will see these cases. I have 3
uestions for you.
The first concerns operative technique. When you go in for a
e-repair, do you generally find it necessary to take down the entire
revious operation and start over, or do you use a more directed
pproach and fix whatever appears to be broken?
Dr Suri. Thank you, Dr Gillinov. At the time of re-repair, the
athology found by the operating surgeon influences the valvulo-
lasty technique used. Generally, we address the specific anatomic
eature requiring correction. Additionally, we always ensure that
e maintain adequate posterior annular support by anchoring a
osterior annuloplasty band between the left and right fibrous
rigones.
Dr Gillinov. My second question concerns any potential
hanges during the time frame of this study, which spans more
han 3 decades. Has there recently been a greater tendency to
e-repair the valves as the surgeons have gained more experience?
Dr Suri. That is a good question. There is no doubt over the
ourse of the 35-year study that trends and techniques have
volved. In the 1990s, we benefited from the data from yourself
nd others using new valvuloplasty techniques for correction of
L prolapse, including the placement of artificial polytetrafluoro-
thylene neochordae. As the comfort level with these techniques
ncreased, so also did the rate of MV re-repair. That said, the
requency with which one encounters a patient with a re-repairable
V is still greater than the number that currently undergo re-
epair. The reason for this can be broadly divided into 2 categories:
atient-related factors and surgeon-related factors. Some patients
resent to the office with recurrent MR after failure of initial
epair, convinced that they require replacement either because they
ave been counseled elsewhere to request it or they believe for
ome reason that because the first repair failed, replacement might
e the more conservative option. We suggest, based on the data we
resent here today, that patients should be assured that there are
istinct benefits of re-repair that warrant its attempt at reoperation.
Regarding surgeon-related factors, there is no doubt that the
olume of primary MV repair that an individual surgeon performs
nfluences how patients are treated when presenting with recurrent
R. This affects how a patient is counseled preoperatively by the
urgeon, the breadth of re-repair techniques attempted intraopera- p
396 The Journal of Thoracic and Cardiovascular Surgery ● Decively, and the outcomes attained. The final adjunct important to a
urgeon’s comfort with re-repair of the MV is the availability of
eliable intraoperative echocardiography to ensure adequate qual-
ty control of re-repair before leaving the operating room. In
ummary, as we accumulate data confirming the clear advantages
f mitral re-repair, patients, referring physicians, and surgeons will
e comforted by the realization that the benefits of primary MV
epair persist after re-repair.
Dr Gillinov. I have one final question. Patients undergoing a
e-repair had superior clinical outcomes. Why do you think this is?
ight it be related to preservation of the subvalvular apparatus
ith repair versus replacement?
Dr Suri. There is certainly good evidence, as others have
iscussed already at this meeting, regarding the benefit of preser-
ation of the mitral subvalvular apparatus in the maintenance of
eft ventricular function and regression of left ventricular dimen-
ions toward normal values. The philosophy at our institution is to
aintain chordal integrity whenever possible. Over the 35-year
eriod of this study, 93% of patients undergoing replacement for
hom data were available had some degree of chordal preserva-
ion. Nonetheless, the extent of chordal preservation during valve
epair might be more complete, and this might partially explain the
dvantages in survival and ventricular recovery over valve replace-
ent.
Dr Gillinov. Thank you.
Dr Paul Kurlansky (Miami, Fla). I want to congratulate you
n a very clear and beautifully presented study, as we have come
o always expect from the Mayo Clinic. I have a couple of brief
uestions.
You mentioned that approximately half of the re-repairs were
ue to technical problems and the other approximately half to new
athology, with a certain amount being caused by ring dehiscence.
was wondering whether you could help teach us—even though
nderstanding that this represents only 3% per year, so it is a
elatively small amount—but what you could teach us about what
ou learned from the technical problems that you encountered. Is
here anything that you learned that could help us to prevent
roblems the first time around, specifically in regard to the tech-
ical issues that you confronted at re-repair?
Second, I wonder whether there is any technical advice that you
an give us regarding ring dehiscence, ways that might predispose
o it and ways that might help prevent it.
Third, regarding new pathology, was this an issue of progres-
ive valve degeneration in the setting of degenerative disease or
as this a new pathology, a new ischemic MR in a patient who did
ot have ischemia at the time of the original operation, is this
rogression of rheumatic disease, et cetera? Were you were able to
ease any of that out?
Thank you.
Dr Suri. Thank you. Those are important questions. It was a
rivilege to review these data because it was a true historic
ummary of the evolution of MV repair. Reviewing the revolu-
ionary techniques used by Professors Kirklin and McGoon in their
arly operative notes, it was fascinating to follow how initial
ttempts were modified to attain the current permanence of MV
epair. As an example, the initial technique for correction of
egmental leaflet prolapse involved what was called a “McGoon
lication.” However, it was subsequently discovered that merely
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CDlicating redundant prolapsing leaflet tissue led to excessive bulk,
hich might have predisposed to early senescence of the repair.
nderstanding that a plication essentially removed a triangular-
haped portion of the leaflet from the coaptation area led to the
volution of a simple triangular resection of the prolapsing seg-
ent, followed by suture reconstruction instead. Because the leaf-
et redundancy caused by choral or rupture is most problematic
ear the coaptation point, resection toward the base of the leaflet
oward the annulus was determined to be unnecessary. Similarly,
arly use of bicommissural annuloplasty stitches was often found
o be ineffective at reoperation, allowing progressive dilation
f the posterior annulus. This observation led to the practice of
nchoring posterior annuloplasty bands in the fibrous skeleton of
he heart between the right and left trigones. Those were some
f the interesting lessons from the early days of MV repair at the
ayo Clinic.
Regarding the current modes of failure, I do not think that there
re necessarily any novel insights that we could offer beyond those
hat are currently published. Even with annuloplasty band place-
ent, one factor that was common in those with either annulo-
lasty dehiscence or progressive annular dilation was the failure to
ttain or maintain anchoring of the band of the initial repair in the
brous trigones.
The issue of new pathology was also interesting. There was a
roportion of the population in our study in whom repair failure
ould be accounted for by progression of Barlow’s-type myxoma-
ous leaflet degeneration. However, there were certain patients in
hom it seemed that correction of the segmental prolapse might
ave led to the redistribution of forces and failure of adjacent
eaflet segments. Even though a ruptured chord might not have
een identified on a bordering segment initially, there were new
uptured chords identified at reoperation. It might be that structur-
lly important cords of questionable integrity might be best ad-
ressed at the time of primary repair.
Finally, the issue of ischemic pathology leading to recurrent
R is worthy of further examination. In a study we presented
arlier this year at the Society of Thoracic Surgeons, coronary
rtery bypass grafting turned out to be an independent predictor of
eoperation after primary MV repair. Initially we were puzzled by
his, but we hypothesize that there might be a component of
volving ischemic disease that is responsible for subsequent isch-
mic MR. This issue will be studied further in future studies.
Thank you for those questions.
Dr Khalid Rasheed (Islamabad, Pakistan). Congratulations on
his very elegant presentation. You did mention that in most of
our patients who needed MV replacement, you did preserve some
f the subvalvular apparatus. Do you generally preserve the entire
ubvalvular apparatus or only that of the posterior mitral leaflet?
ow that it has generally been shown that the entire annulus
ilates, including the intertrigonal area, what were your reasons for
ot selecting a complete ring, either rigid or flexible?Thank you. c
The Journal of ThoracicDr Suri. Those are good questions and probably extend beyond
he time we have allocated today. Just quickly, the subvalvular
pparatus was preserved to differing extents over the 35-year
eriod, but in those for whom data were available, 93% had some
egree of chordal preservation.
Regarding progressive dilation of the annulus, although there
re new data suggesting that the anterior annulus might elongate
etween trigones, there is still debate regarding the category of
atients at risk, along with the quantitative and qualitative ele-
ents of the phenomenon. Although we did not specifically mea-
ure the anterior intertrigonal distance, what I can say is that in the
bsence of leaflet pathology, recurrent MR at the time of reopera-
ion was unusual in the setting of a posterior annuloplasty band
hat remained anchored between the left and right fibrous trigones.
Dr David H. Adams (New York, NY). Rakesh, it is just a
ollow-up to what we have just been talking about. I believe you
aid you use a standard-length 63-mm band in everyone, and then
ou said one of the reasons for failure was an inability to secure it
t the trigones. Are you sure that part of the problem here is not a
ethodologic one? You do not have enough of a downsized
nnuloplasty? And we did not really have time to talk about it, but
ow many failures were caused by the annuloplasty being revised
s part of the treatment?
Also, when you say you could not secure it at the trigones,
aybe you did secure it and the anterior annulus did dilate. Is that
ossible, do you think?
Dr Suri. Thank you, Dr Adams. I appreciate your comments.
ifty-two of the 64 required some manipulation, placement, or
eplacement of an annuloplasty ring for differing reasons. Over the
5-year period, the most homogenous trend that we can speak to in
erms of the discovery of an annular cause of recurrent MR at the
ime of reoperation was either the absence of a prosthetic annulo-
lasty device or finding that the initial annuloplasty band was not
nchored into one or both fibrous trigones.
Regarding sizing, we most commonly use a standard 63-mm
and for degenerative MV repair. We initially chose that size
ased on pathologic cross-sectional data derived from our institu-
ion in the 1980s, which demonstrated that the average posterior
nnular length between fibrous trigones in the normal human heart
as 63 mm. Now while placing that band, there is a slight amount
f tapering that is possible based on stitch width and the degree of
inching performed while tying the knots down. This allows us
ome adjustment for heart size and systolic anterior motion risk.
inally, I understand that there is still significant debate among
enters regarding partial versus complete rings and ring size. As Dr
uran stated this morning, there might be—and I am offering this
s a hypothesis—more controversy about bands and rings in purely
egenerative MV disease than is necessary or warranted based on
he science we have available. I merely offer that for consideration
ntil we have the data from randomized studies to understand the
oncept further.
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